Quantinno Capital Management LP Raises Stock Position in Oscar Health, Inc. $OSCR

by · The Cerbat Gem

Quantinno Capital Management LP lifted its holdings in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) by 338.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 135,717 shares of the company’s stock after acquiring an additional 104,770 shares during the quarter. Quantinno Capital Management LP’s holdings in Oscar Health were worth $1,557,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in OSCR. Focus Partners Wealth raised its position in Oscar Health by 1.4% in the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after purchasing an additional 824 shares during the period. Equitable Holdings Inc. boosted its position in shares of Oscar Health by 7.0% in the fourth quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock worth $186,000 after buying an additional 850 shares during the period. Captrust Financial Advisors boosted its position in shares of Oscar Health by 2.0% in the fourth quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock worth $657,000 after buying an additional 895 shares during the period. O Shaughnessy Asset Management LLC grew its stake in shares of Oscar Health by 5.6% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock valued at $255,000 after buying an additional 938 shares in the last quarter. Finally, Binnacle Investments Inc grew its stake in shares of Oscar Health by 28.6% in the third quarter. Binnacle Investments Inc now owns 4,500 shares of the company’s stock valued at $85,000 after buying an additional 1,000 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Price Performance

Shares of OSCR stock opened at $29.79 on Thursday. The firm has a fifty day moving average of $29.35 and a two-hundred day moving average of $20.67. The firm has a market cap of $8.98 billion, a P/E ratio of 21.28, a P/E/G ratio of 0.58 and a beta of 2.36. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $33.10. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11.

Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 44.96%. The company’s quarterly revenue was up 70.4% compared to the same quarter last year. During the same quarter last year, the company posted ($0.89) earnings per share. As a group, research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Mark T. Bertolini sold 624,244 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $28.48, for a total value of $17,778,469.12. Following the completion of the sale, the chief executive officer directly owned 7,751,570 shares in the company, valued at approximately $220,764,713.60. The trade was a 7.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 31,683 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $695,125.02. Following the completion of the sale, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This trade represents a 2.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 3,562,466 shares of company stock valued at $102,829,815 over the last three months. Company insiders own 22.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on OSCR shares. UBS Group boosted their price target on Oscar Health from $20.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, August 7th. Barclays increased their price objective on shares of Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Wolfe Research assumed coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday. Finally, Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $25.44.

Get Our Latest Stock Analysis on Oscar Health

Oscar Health Company Profile

(Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Further Reading

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).